Abstract #2768

Ethanolamine Kinase-1 as a Potential Therapeutic Biomarker in Pancreatic Cancer

Tariq Shah¹, Balaji Krishnamachary¹, Flonne Wildes¹, Jannie Wijnen², Kristine Glunde¹, and Zaver M Bhujwalla¹

¹Radiology, Johns Hopkins University, Baltimore, MD, United States, ²Utrecht, Netherlands

In understanding the aberrant choline metabolism of cancer, significant effort has been focused on phosphocholine (PC) but the role of phosphoethanolamine (PE) is relatively underexplored, even though tumors show increased PE as consistently as increased PC. Our previous findings in breast cancer cells have led us to expand our study to understand the role of ethanolamine kinase-1 (EtnK-1) and PE in pancreatic cell lines. We have demonstrated that EtnK-1 is the major contributor to PE levels in these cells and may be a potential therapeutic target.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.